[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-363570-105":59,"doc-detail-363570-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","diagnostic-implications-of-multi-cancer-early-detection-testing-in-the-investigation-of-cancer-symptoms-an-exploratory-retrospective-analysis-of-the-symplify-study","Diagnostic Implications of Multi-Cancer Early Detection Testing in the Investigation of Cancer Symptoms - An Exploratory Retrospective Analysis of the SYMPLIFY Study","","The SYMPLIFY observational study assessed accuracy of a multi-cancer early detection (MCED) test in referred symptomatic participants. This exploratory retrospective analysis evaluates how the MCED test could enable faster or more efficient diagnosis when used to guide clinical work-up. Cancer diagnoses were reviewed using study site data plus two years of registry data, classifying outcomes by symptom-referral pathways and MCED cancer signal origin predictions.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/diagnostic-implications-of-multi-cancer-early-detection-testing-in-the-investigation-of-cancer-symptoms-an-exploratory-retrospective-analysis-of-the-symplify-study/363570/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/diagnostic-implications-of-multi-cancer-early-detection-testing-in-the-investigation-of-cancer-symptoms-an-exploratory-retrospective-analysis-of-the-symplify-study/363570.png","ImageObject",300,407,{"name":92,"@type":93},"Elsa","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How were cancer diagnoses evaluated in the SYMPLIFY analysis?","Question",{"text":112,"@type":113},"The study reviewed all cancers diagnosed in SYMPLIFY using data collected at study sites and two years of cancer registry data. Diagnoses were classified by alignment between participant symptoms, referral pathways, MCED predicted cancer signal origin, cancer site, and time to diagnosis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What did the analysis find about false positive MCED results?",{"text":117,"@type":113},"Among participants with an apparent false positive MCED result, 35% were later diagnosed with cancer based on registry data, substantially increasing the MCED positive predictive value. Only one of the additional cases showed a cancer site incongruent with the predicted MCED cancer signal origin.",{"name":119,"@type":110,"acceptedAnswer":120},"Could MCED results speed up or slow down diagnosis?",{"text":121,"@type":113},"For 19% of diagnosed cancers, the MCED result might have contributed to a more efficient diagnosis if used in clinical work-up. Conversely, 9% of cancers might have taken longer if investigations were directed solely by an incorrect MCED cancer signal origin prediction.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},363570,1790323467,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},137455077381,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Articles  \nDiagnostic Implications of Multi-Cancer Early Detection Testing in the Investigation of Cancer Symptoms: An Exploratory Retrospective Analysis of the SYMPLIFY Study  \nAshley Jackson,a,b PradeepS. Virdee,a Sharon Tonner,a Jason L. Oke,a Rafael Perera,a Kaveh Riahi,c Sara Hiom,c Harpal Kumar,c F. D. Richard Hobbs,a Mark R. Middleton,d and Brian D. Nicholsona,∗  \naNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK bDepartment of Medicine, University of Ottawa, Ottawa, Ontario, Canada  \ncGRAIL Bio UK, Ltd., London, UK  \ndDepartment of Oncology, University of Oxford, Oxford, UK  \nSummary  \nBackground The observational SYMPLIFY study reported the accuracy of a multi-cancer early detection (MCED) test in a referred symptomatic population. We explore how the MCED test may contribute to a faster or more efficient diagnosis if acted upon.  \nMethods We reviewed all cancers diagnosed in SYMPLIFY (ISRCTN10226380) using data collected at study sites plus two years of cancer registry data. All cancer diagnoses were classified based on the congruence between the participant’s symptoms, diagnostic referral pathway, MCED test cancer signal origin (CSO) prediction, cancer site, and time to diagnosis.  \nFindings There were 533 cancers diagnosed among 5461 (9.8%) evaluable participants in SYMPLIFY during the 2-year follow-up period. Among the 79 participants with an apparent false positive test result in the original SYMPLIFY study, 28 (35%) were diagnosed with cancer based on cancer registry data, increasing the MCED PPV to 84.2%(80.1–87.6) . In aggregate, only one of the 28 additional patients had a cancer diagnosed that was incongruent with a predicted MCED CSO. Among the 5014 patients with an apparent true negative MCED test result, 113 (2%) received a subsequent cancer diagnosis. In 101 (19%) of the 533 cancers diagnosed, the MCED test result might have contributed to a more efficient diagnosis had it been used to inform the clinical work-up. Conversely, 49 (9%) cancers might have taken longer to diagnose if the MCED test result alone had been used in the diagnostic process, directing investigations based upon an incorrect CSO prediction.  \nInterpretation These exploratory findings demonstrate a substantially higher rate of cancer diagnoses in symptomatic participants originally classified with a false positive MCED test result than those originally classified as true negative. We show how MCED tests have the potential to assist clinical decision making, which may in turn lead to a timelier cancer diagnosis for one fifth of cancers diagnosed.  \nFunding GRAIL Bio UK, Ltd. NIHR.  \nCopyright © 2026 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license ([http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/)).  \nThe Lancet Regional Health - Europe 2026;66: 101720  \nPublished Online xxx [https://doi.org/10](https://doi.org/10) . 1016/j.lanepe.2026 . 101720  \nKeywords: MCED; Early diagnosis; Cancer; False positive  \nIntroduction  \nGlobally, cancer presents a significant health burden, with estimates suggesting that approximately half of all people will receive a cancer diagnosis during their lifetime.1 When cancer is detected early there are a greater number of, and more effective, treatment  \noptions available, resulting in better survival.2 However, currently approximately half of all cancers are diagnosed at an advanced stage, resulting in high morbidity and mortality.3 Many countries are making early cancer detection a priority. A key element of the Faster Diagnosis Standard (FDS) of the English National Health  \n*Corresponding author. Nuffield Department of Primary Care Health Sciences, Radcliffe Primary Care Building, Radcliffe Observatory Quarter, Woodstock Road, Oxford, OX2 6GG, UK.  \nE-mail [address:](address: brian.nicholson@phc.ox.ac.uk)[ brian.nicholson@phc.ox.ac.uk](address: brian.nicholson@phc.ox.ac.uk) (B.D. Nicho","cbCaif5OfZ9pAQUt","https://ap.wps.com/l/cbCaif5OfZ9pAQUt","pdf",1973486,12,"English","# Summary\n## Background\n## Methods\n## Findings\n## Interpretation\n## Funding\n## Introduction\n# Research in context\n## Evidence before this study\n## Added value of this study","[{\"question\":\"How were cancer diagnoses evaluated in the SYMPLIFY analysis?\",\"answer\":\"The study reviewed all cancers diagnosed in SYMPLIFY using data collected at study sites and two years of cancer registry data. Diagnoses were classified by alignment between participant symptoms, referral pathways, MCED predicted cancer signal origin, cancer site, and time to diagnosis.\"},{\"question\":\"What did the analysis find about false positive MCED results?\",\"answer\":\"Among participants with an apparent false positive MCED result, 35% were later diagnosed with cancer based on registry data, substantially increasing the MCED positive predictive value. Only one of the additional cases showed a cancer site incongruent with the predicted MCED cancer signal origin.\"},{\"question\":\"Could MCED results speed up or slow down diagnosis?\",\"answer\":\"For 19% of diagnosed cancers, the MCED result might have contributed to a more efficient diagnosis if used in clinical work-up. Conversely, 9% of cancers might have taken longer if investigations were directed solely by an incorrect MCED cancer signal origin prediction.\"}]","Diagnostic Implications of Multi-Cancer Early Detection Testing in the Investigation of Cancer Symptoms - An Exploratory Retrospective Analysis of the SYMPLIFY Study | PDF",1790151885,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d37538babb464b32854ca4d66ee0364d.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f4d953c07856710a3b4e45accfa3e7fe.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/30e83b7ce637871ce566cb08d33083a0.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6a3e1a035bc969048fe3578b5f33524a.webp",980,1306]